Larvol Delta - Phase-1-Study-of-ACE232-to-Treat-Patients-with-Metastatic-CastrationResistant-Prostate-Cancer

ACE-232 - Acerand Therap

http://clinicaltrials.gov/ct2/show/NCT06801236

Jan 30, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next